Velomedix has obtained regulatory approval from Health Canada for its pilot study of Velomedix rapid therapeutic hypothermia system, designed for use in patients with acute myocardial infarctions (AMIs or heart attacks). The Velomedix ...
Tags: Velomedix, egulatory approval, Health Canada